Report outlines measures to combat antibiotic resistance
The researchers argue that without the economic incentives they propose, new treatments to use in the fight against antibiotic-resistant bacteria may never make it to patients.
Keystone
A plan to fight back against antibiotic resistance, developed by an international consortium managed by Swiss researchers, calls for marketing incentives for research and development investments into crucial new drugs.
This content was published on
2 minutes
SDA-ATS/ln
Researchers and public health organisations have long been raising awareness about the problem of antibiotic-resistant bacteria, and the lack of new treatments being developed to combat these strains.
Now, DRIVE-ABExternal link, an international consortium of public health organisations, researchers and pharmaceutical companies piloted by the University of Geneva (UNIGE) and England-based AstraZenecaExternal link, has published a report that proposes concrete economic solutions to combat this global problem.
In particular, the writers of the report, published WednesdayExternal link, recommend a market entry reward for antibiotics fulfilling certain conditions to meet the health needs of the public, in order to create more attractive conditions for research and development investments.
They argue that such a reward – involving a series of payments to a pharmaceutical developer for getting regulatory approval for a certain antibiotic – of $1 billion (CHF940 million) per product could significantly increase the number of new drugs entering the market in the next 30 years. Such a financial incentive would be accompanied by requirements for responsible use of and equitable access to these medicines, they write.
Stephan Harbarth, a professor at the University of Geneva Faculty of Medicine and the coordinator of the DRIVE-AB project, said in a statement that implementing such incentives would take time. He emphasised that it is therefore imperative to act quickly, so that “these new antibiotics will be at our disposal in the next ten to 20 years”.
Other models analysed in the report include non-refundable research grants, the creation of government organisations to identify and fill holes in the global antibiotic pipeline, and long-term financing to guarantee a stable supply of generic antibiotics.
The consequences of antibiotic resistance are severe and on the rise. For the first time last year, Switzerland launched its own campaign in parallel to the World Health Organization’s annual Antibiotic Awareness Week, to educate the public as well as experts on issue.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
This content was published on
The earth shook near Mürren in the Bernese Oberland on Monday afternoon with a magnitude of around 4.2 on the Richter scale.
Public transport in Geneva faces calls for overhaul
This content was published on
Public transport services in Greater Geneva must better meet needs. The associations Transports et environnement (ATE) and Rail Dauphiné Savoie Léman (ARDSL) have drawn up a review of the situation, calling in particular for the Leman Express timetable to be extended.
Swiss politician who shot at baby Jesus risks fine
This content was published on
The Zurich public prosecutor's office has brought charges against Zurich city parliamentarian Sanija Ameti for disturbing religious freedom. Ameti had shot at a picture of Jesus and Mary with an air pistol.
This content was published on
The French-Swiss artist Saype has created a new giant painting on the summit of the Grand Chamossaire above Villars-sur-Ollon VD. The 2500 square metre work depicts a boy with a rucksack on his shoulders.
This content was published on
According to "Schweizer Illustrierte", Swiss actor Carlos Leal is returning to Switzerland - after 15 years in Los Angeles. "It's become loud there, megalomaniacal and arrogant," he said in the online edition of the magazine.
This content was published on
A coin collector has filed a criminal complaint with the Office of the Attorney General of Switzerland against Swissmint, the federal mint, for fraud in connection with the sale of the limited-edition 100-franc gold Vreneli.
Museum to open devoted to Swiss ski legend Vreni Schneider
This content was published on
Vreni Schneider is to have a museum in the centre of her home village of Elm. The legendary Swiss ski racer has numerous memorabilia at home, which she is now releasing and exhibiting.
This content was published on
A shooting range in Wittenbach, northeastern Switzerland, was broken into on Sunday night. The unknown perpetrators stole several antique weapons.
Euro 2025: most of crowd at Germany-France match were women
This content was published on
For the first time, the majority of the crowd at a football match in Basel's St. Jakob-Park – Saturday's European Championship quarterfinal – was female.
Pilots’ union seeks to end deal with SWISS over working conditions
This content was published on
The Aeropers pilots’ union is expected to end its collective labour agreement with SWISS, as it pushes for better working conditions for its members.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Lucerne research finds how to cut antibiotic overuse in babies
This content was published on
Researchers has successfully tested a way of targeting antibiotic therapy in new-born babies, thereby avoiding unnecessary treatment and side effects.
This content was published on
Nina Kathe has just started classes at the University of Zurich, but she’s already the author of award-winning research into a global health concern.
Anti-pesticide farm initiative passes the signature stage
This content was published on
Campaigners have handed in signatures backing an initiative which would cut direct subsidies to farmers who use pesticides or antibiotics.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.